BioCentury | May 5, 2016
Distillery Therapeutics

Therapeutics: MicroRNA-22 (miR-22)

...myelogenous leukemia (AML) Mouse studies suggest miR-22 could help treat AML. In AML patient samples, miR-22...
...compared with an inactive mutant miR-22. Next steps could include testing nanoparticle-based methods of delivering miR-22...
...Next steps could include testing nanoparticle-based methods of delivering miR-22 in other AML models. TARGET/MARKER/PATHWAY: MicroRNA-22 (miR-22)...
BioCentury | Nov 12, 2015
Distillery Therapeutics

Therapeutics: MicroRNA-22 (miR-22)

...disease Patient sample and mouse studies suggest inhibiting miR-22 could help treat emphysema. Levels of miR-22...
...from healthy controls. In mice exposed to cigarette smoke or nanoparticulate carbon black, knockout of miR-22...
...Next steps include developing and testing miR-22 antagonists and delivery vehicles in emphysema models. TARGET/MARKER/PATHWAY: MicroRNA-22 (miR-22)...
Items per page:
1 - 2 of 2